Sykehusinnkjøp HF 916879067 Vadsø Vibecke Lindøen +47 91851714 vibecke.lindoen@sykehusinnkjop.no http://permalink.mercell.com/70542706.aspx http://www.sykehusinnkjop.no/ procurement central Procurement of NIM3 for the parotid gland, ear surgery and endocrine throat interventions. 2017/585 Sykehusinnkjøp HF divisjon vest, is a procurement company that makes procurements and manages contracts on behalf of Helse Vest RHF with underlying companies. Sykehusinnkjøp HF divisjon vest is acting on behalf of Helse Bergen HF in this competition. Helse Bergen HF intends to enter into a contract with Medtronic Norge AS for the procurement of two NIM 3.0 apparatuses with various accessories (listed in the price offer) and instrument dependent consumables. The apparatuses will be used by the Central Surgery Department at the ENT Department, Clinic for Head-Throat and at the Department for Chest and Endocrine Surgery, Surgical Clinic, at Haukeland University Hospital. The NIM 3.0 apparatuses will be used for tissue surgery and ear surgery in order to prevent fascia paresis (ENT) and for endocrine throat interventions (endocrine surgery) in order to identify the laryngeal recurrence nerve (vocal chord nerve) and to avoid damaging it. An option is wanted for a third apparatus and possibly a service contract after the guarantee period has expired. 7000000.00 Helse Bergen HF. NIM 3.0 — Advanced nerve monitoring system will be used as intended (see the previous section). Theatre nurses work in several departments and a standardisation will mean that the theatre nurses will be familiar with handling such equipment. This will increase patient safety in the departments. The established procedures in the departments are adapted to the current NIM apparatuses. ENT has advanced interventions where they operate in a hypeglossus stimulator. This procedure is validated up against a NIM apparatus and they use Medtronic's Bipolar stimulation probe. Nerve monitoring in endocrine throat interventions is currently standard in endocrine surgery centres. NIM 3.0 also gives good options for continual monitoring (use of the APS probe). NIM 3.0 apparatus with accessories (priced in the tender). Possible service contract after the guarantee period. The NIM 3.0 apparatuses will be used by surgeons for tissue surgery and ear surgery in order to prevent fascia paresis (ENT) and for endocrine throat interventions (endocrine surgery) in order to identify the laryngeal recurrence nerve (vocal chord nerve) and to avoid damaging it. Theatre nurses work in several departments and a standardisation will mean that the theatre nurses will be familiar with handling such equipment. This will increase patient safety in the departments. The established procedures in the departments are adapted to the current NIM apparatuses. In addition, ENT has an advanced intervention where they operate in a hypoglossus stimulator. This procedure is validated up against a NIM apparatus and they use Medtronic's Bipolar stimulation probe. Nerve monitoring in endocrine throat interventions is currently standard in endocrine surgery centres. NIM 3.0 also gives good options for continual monitoring (use of the APS probe). Cf. FOA §13-4, c. 2017-06-16 Medtronic Norge AS 975806529 Lysaker 7000000.00 Sykehusinnkjøp HF Bergen +47 91851714 vibecke.lindoen@sykehusinnkjop.no Klagenemnda for offentlige anskaffelser Postboks 439 Sentrum Bergen 5805 +47 55597500 post@kofa.no +47 55597599 http://www.kofa.no/ 2017-06-22
See tender at TED: http://ted.europa.eu/udl?uri=TED:NOTICE:241816-2017:TEXT:EN:HTML